Aflibercept
TED · 650089-2026Contract noticeCloses in 14 days · 2026-10-06
Buyer
Name—
Country—
Published2026-09-21
Deadline2026-10-06
Value
Estimated—
Awarded—
CPV codes
33662100 Medical equipment & pharmaceuticalsDescription
Le marché concerne les fournitures de spécialité pharmaceutique contenant le principe actif « Aflibercept » en solution injectable intravitréenne.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-28 | Aflibercept | — | 100% |
| 2026-08-19 | Infliximab | — | 94% |
| 2026-08-31 | Pirfénidone | — | 93% |
| 2026-05-19 | Pomalidomide | — | 93% |
| 2026-08-19 | Rituximab | — | 92% |
| 2026-07-07 | Bévacizumab | — | 91% |